The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, China; Internal Medicine Department One, Wenjiang Traditional Chinese Medicine Hospital of Chengdu, Chengdu, China.
The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, China; Traditional Chinese Medicine Hospital of Long Chang City, Neijiang, China.
J Ethnopharmacol. 2023 Aug 10;312:116521. doi: 10.1016/j.jep.2023.116521. Epub 2023 Apr 18.
Hemorrhagic transformation after acute ischemic stroke is a life-threatening disease that currently has no effective chemotherapy. Zhilong Huoxue Tongyu Capsule (ZL) is an empirical prescription of traditional Chinese medicine that is used to prevent and treat cardiovascular and cerebrovascular diseases in China. However, only a few studies have addressed the mechanisms of ZL in treating hemorrhagic transformation.
To evaluate the anti-inflammatory effects of ZL on hemorrhagic transformation model rats and lipopolysaccharide (LPS)-induced RAW264.7 macrophages and to explore the underlying molecular mechanisms.
Murine RAW264.7 cells were treated with ZL and LPS (1 μg/mL), and cell viability was detected by cell counting kit-8 assay. RT-qPCR was used to detect the expression of inflammatory chemokines, microRNA let-7a/e/i/f, toll like receptor 4 (TLR4), myeloid differentiation factor 88 (MyD88), and nuclear factor kappa-B (NF-κB) p65. The protein expression levels of TLR4, MyD88, NF-κB p65, and apoptosis related molecules were determined by Western blotting. The apoptosis rate of RAW264.7 macrophages was detected by Annexin V-FITC/PI double staining. A hemorrhagic transformation model in rats was established by intraperitoneal injection of high glucose solution combined with thread embolization. Then, the model rats were observed behaviourally, pathologically, and molecularly. The gene expression of TLR4, MyD88, and NF-κB p65 was measured by RT-qPCR and used to evaluate the protective effect of ZL against hemorrhagic transformation in rats.
ZL (5, 20, 40 μg/mL) was beneficial in cell proliferation. LPS (1 μg/mL) stimulated the production of inflammatory chemokines and inhibited the production of let-7a/e/i/f, with let-7f being influenced most strongly. Moreover, overexpression of let-7f decreased the gene and protein levels of TLR4, MyD88, and NF-κB p65, downregulated TLR4, and inhibited its transcriptional activity. ZL (5, 20, and 40 μg·mL-1) inhibited the production of TLR4, MyD88, and NF-κB p65 and promoted the production of let-7f in a concentration-dependent manner. Furthermore, the blockade of TLR4 antagonized the promoting effects of TLR4 pathway activation in cell inflammation and apoptosis by downregulating let-7f. Critically, it was confirmed in vivo and in vitro that ZL upregulated the expression of let-7f and inhibited the gene expression of TLR4, MyD88, and NF-κB p65 to reduce inflammatory cell infiltration, which determined the occurrence of hemorrhagic transformation.
ZL can reduce inflammatory response by upregulating let-7f and subsequently inhibiting the TLR4 signaling pathway, thereby decreasing the occurrence of hemorrhagic transformation.
急性缺血性脑卒中后的出血性转化是一种危及生命的疾病,目前尚无有效的化学疗法。蛭龙活血通瘀胶囊(ZL)是一种中药经验方,在中国用于预防和治疗心脑血管疾病。然而,只有少数研究探讨了 ZL 治疗出血性转化的机制。
评估 ZL 对出血性转化模型大鼠和脂多糖(LPS)诱导的 RAW264.7 巨噬细胞的抗炎作用,并探讨其潜在的分子机制。
用 ZL 和 LPS(1μg/mL)处理鼠 RAW264.7 细胞,用细胞计数试剂盒-8 法检测细胞活力。通过 RT-qPCR 检测炎症趋化因子、miRNA let-7a/e/i/f、Toll 样受体 4(TLR4)、髓样分化因子 88(MyD88)和核因子 kappa-B(NF-κB)p65 的表达。通过 Western blot 测定 TLR4、MyD88、NF-κB p65 和凋亡相关分子的蛋白表达水平。通过 Annexin V-FITC/PI 双重染色检测 RAW264.7 巨噬细胞的凋亡率。通过腹腔注射高渗溶液结合线栓栓塞建立大鼠出血性转化模型。然后,对模型大鼠进行行为学、病理学和分子学观察。通过 RT-qPCR 测量 TLR4、MyD88 和 NF-κB p65 的基因表达,以评估 ZL 对大鼠出血性转化的保护作用。
ZL(5、20、40μg/mL)有益于细胞增殖。LPS(1μg/mL)刺激炎症趋化因子的产生,抑制 let-7a/e/i/f 的产生,其中 let-7f 受影响最大。此外,let-7f 的过表达降低了 TLR4、MyD88 和 NF-κB p65 的基因和蛋白水平,下调了 TLR4 并抑制了其转录活性。ZL(5、20 和 40μg·mL-1)以浓度依赖的方式抑制 TLR4、MyD88 和 NF-κB p65 的产生,并促进 let-7f 的产生。此外,TLR4 阻断剂通过下调 let-7f 拮抗 TLR4 通路激活对细胞炎症和凋亡的促进作用。至关重要的是,在体内和体外均证实 ZL 通过上调 let-7f 并抑制 TLR4、MyD88 和 NF-κB p65 的基因表达来减少炎症细胞浸润,从而决定了出血性转化的发生。
ZL 可通过上调 let-7f 抑制 TLR4 信号通路,从而减少炎症反应,降低出血性转化的发生。